MRNA - JN.1 Omicron strain becomes dominant COVID variant in U.S.
2023-12-26 07:02:44 ET
More on BioNTech, Moderna, etc.
- BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline
- Pfizer: Buy The Panic
- Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think
- Citi puts Pfizer on catalyst watch after conservative 2024 outlook
- FDA approves Keytruda/Padcev combo therapy for bladder cancer
For further details see:
JN.1 Omicron strain becomes dominant COVID variant in U.S.